Transkaryotic Therapies' Other Investors

Transkaryotic Therapies raised a round of funding on , . Investors include Thomas McNerney & Partners.

Transkaryotic Therapies (NASDAQ: TKTX) develops technologies for the production of human proteins and for gene therapy systems. Products developed with these technologies include ReplagalT, a drug app…

Articles about Transkaryotic Therapies' Other Investors: